Cell Therapy Analytical Development Intern
Bristol Myers Squibb
Summary
The intern will support the development of cell-based bioassays within the Cell Therapy Analytical Development Team. The intern will contribute to multiple assays at different stages of maturity, from early development and proof-of-concept studies through phase-appropriate validation and transfer. This role offers hands-on laboratory experience in assay development, data analysis, and scientific documentation. The intern will collaborate with scientists to help deliver robust, fit-for-purpose assays that meet regulatory expectations.
Job description
Position Summary
The intern will support the development of cell-based bioassays within the Cell Therapy Analytical Development Team. The intern will contribute to multiple assays at different stages of maturity, from early development and proof-of-concept studies through phase-appropriate validation and transfer. This role offers hands-on laboratory experience in assay development, data analysis, and scientific documentation. The intern will collaborate with scientists to help deliver robust, fit-for-purpose assays that meet regulatory expectations.
Key Responsibilities
- Support the design, development, and optimization of cell-based bioassays, including early feasibility and proof-of-concept studies for gene edited programs
- Perform laboratory experiments, including cell culture, molecular biology and cell-based assay techniques, sample preparation, assay execution, and data collection
- Evaluate key assay parameters such as accuracy, precision, linearity, range, and robustness to assess assay performance and fitness for purpose
- Analyze and interpret experimental data, applying statistical tools to support assay design decisions and conclusions
- Document experimental procedures, results, and observations in electronic laboratory notebooks, may assist in drafting protocols, reports, and technical summaries
- Collaborate with team members to troubleshoot assay performance issues
- Present findings and progress in team meetings, including a final summer project presentation
- Maintain laboratory safety and compliance with standard operating procedures and good documentation practices
Qualifications & Experience
- Currently pursuing a bachelor’s or graduate degree in biology, Biochemistry, Biotechnology, or a related field
- Basic laboratory skills and familiarity with techniques such as mammalian cell culture, ELISA, Western Blot, and PCR
- Understanding of gene editing technologies such as CRISPR
- Strong analytical and problem-solving abilities
- Excellent written and verbal communication skills
- Ability to work independently and as part of a team
- Attention to detail and strong organizational skills
- Available to work during the internship period June 7th - August 13th 2027
- All candidates must be legally authorized to work in the United States at the time of hire and for the duration of their employment
Requirements
- Currently pursuing a bachelor’s or graduate degree in biology, Biochemistry, Biotechnology, or a related field
- Basic laboratory skills and familiarity with techniques such as mammalian cell culture, ELISA, Western Blot, and PCR
- Understanding of gene editing technologies such as CRISPR
- Strong analytical and problem-solving abilities
- Excellent written and verbal communication skills
- Ability to work independently and as part of a team
- Attention to detail and strong organizational skills
- Available to work during the internship period June 7th - August 13th 2027
- Legally authorized to work in the United States without sponsorship
Benefits
- Comprehensive benefits
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.